Abstract: The disclosure relates to dry powder compositions of (a) a plant-based cannabidiol (pCBD) composition, or (b) a plant-based tetrahydrocannabinol composition (pTHC); or (c) a synthetic cannabidiol composition (sCBD), or (d) a synthetic tetrahydrocannabinol composition (sTHC), or (e) a plant-based cannabidiol (pCBD) composition in combination with a a plant-based tetrahydrocannabinol composition (pTHC), or (f) a synthetic cannabidiol composition (sCBD) in combination with a synthetic tetrahydrocannabinol composition (sTHC) and their delivery to the airway of a subject using a dry powder inhaler.
Type:
Application
Filed:
March 18, 2021
Publication date:
April 20, 2023
Applicant:
TFF Pharmaceuticals, Inc.
Inventors:
Glenn MATTES, Aaron FLETCHER, Carlo CASULO
Abstract: The present disclosure provides pharmaceutical compositions of niclosamide that may be administered orally. These compositions may allow the achievement of a therapeutically effective dose of niclosamide while preventing crystallization in the stomach which reduces bioavailability. These compositions may be used to treat one or more diseases or disorders such as a viral infection or cancer.
Type:
Application
Filed:
August 31, 2022
Publication date:
April 13, 2023
Applicants:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, TFF PHARMACEUTICALS, INC.
Inventors:
Robert O. WILLIAMS, III, Zachary N. WARNKEN, Miguel O. Jara GONZALES, John J. KOLENG
Abstract: The disclosure relates to dry powder compositions of (a) a plant-based cannabidiol (pCBD) composition, or (b) a plant-based tetrahydrocannabinol composition (pTHC); or (c) a synthetic cannabidiol composition (sCBD), or (d) a synthetic tetrahydrocannabinol composition (sTHC), or (e) a plant-based cannabidiol (pCBD) composition in combination with a plant-based tetrahydrocannabinol composition (pTHC), or (f) a synthetic cannabidiol composition (sCBD) in combination with a synthetic tetrahydrocannabinol composition (sTHC) and their delivery to the airway of a subject using a dry powder inhaler.
Type:
Application
Filed:
September 18, 2020
Publication date:
October 27, 2022
Applicants:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, TFF PHARMACEUTICALS, INC.
Inventors:
Robert O. WILLIAMS, III, Chaeho MOON, John J. KOLENG
Abstract: In some aspects, the present disclosure provides methods of preparing pharmaceutical compositions using an suspension based thin film freezing method to obtain inhalable compositions. These compositions may have a higher homogeneity compared to compositions prepared using conventional methods. These compositions may be used to treat or prevent one or more diseases or disorders.
Type:
Application
Filed:
March 11, 2022
Publication date:
October 6, 2022
Applicants:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, TFF Pharmaceuticals, Inc.
Inventors:
Robert O. WILLIAMS, III, Sawittree SAHAKIJPIJARN, Chaeho MOON, John J. KOLENG, JR.